TNFRSF11A
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
The analysis of RANKL, RANK and osteoprotegerin (OPG) expressions in biopsies of a cohort of patients revealed that while RANK expression in osteosarcoma cells was not significantly different between patients with or without metastases at the time of diagnosis, the OPG/RANK ratio decreased significantly.
|
30355966 |
2018 |
TNFRSF11A
|
0.360 |
Biomarker
|
disease |
BEFREE |
Thus, RANK was identified as a negative prognostic factor of osteosarcoma survival.
|
28587351 |
2017 |
TNFRSF11A
|
0.360 |
Biomarker
|
disease |
LHGDN |
Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells.
|
17982618 |
2007 |
TNFRSF11A
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
This is the first report describing a functional RANK expressed on osteosarcoma cells, as shown by its ability to induce signal transduction pathways and biological activity when stimulated by RANKL.
|
16328004 |
2006 |
TNFRSF11A
|
0.360 |
AlteredExpression
|
disease |
LHGDN |
This is the first report describing a functional RANK expressed on osteosarcoma cells, as shown by its ability to induce signal transduction pathways and biological activity when stimulated by RANKL.
|
16328004 |
2006 |
TNFRSF11A
|
0.360 |
Biomarker
|
disease |
BEFREE |
Previous analysis of tumor-specific constitutional LOH had identified a putative tumor-suppressor gene (LOH18CR) active in osteosarcoma tumorigenesis, which mapped to a subregion of chromosome 18q linked to both familial Paget's disease and FEO.
|
12673693 |
2003 |
TNFRSF11A
|
0.360 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Previous analysis of tumor-specific constitutional LOH had identified a putative tumor-suppressor gene (LOH18CR) active in osteosarcoma tumorigenesis, which mapped to a subregion of chromosome 18q linked to both familial Paget's disease and FEO.
|
12673693 |
2003 |
TNFRSF11A
|
0.360 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
These data indicate that TNFRSF11A mutations contribute neither to the vast majority of cases of sporadic or familial PDB, nor to the development of osteosarcoma.
|
11351498 |
2001 |
TNFRSF11A
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
These data indicate that TNFRSF11A mutations contribute neither to the vast majority of cases of sporadic or familial PDB, nor to the development of osteosarcoma.
|
11351498 |
2001 |